Pex13 Inactivation in the Mouse Disrupts Peroxisome Biogenesis and Leads to a Zellweger Syndrome Phenotype

REFERENCES

• Baes, M., P. Gressens, E. Baumgart, P. Carmeliet, M. Casteels, M. Fransen, P. Evrard, D. Fahimi, P. E. Declercq, D. Collen, P. P. van Veldhoven, and G. P. Mannaerts. 1997. A mouse model for Zellweger syndrome. Nat. Genet. 17: 49–57.
   PubMed Web of Science ®Google Scholar
• Baumgart, E., I. Vanhorebeek, M. Grabenbauer, M. Borgers, P. E. Declercq, H. D. Fahimi, and M. Baes. 2001. Mitochondrial alterations caused by defective peroxisomal biogenesis in a mouse model for Zellweger syndrome (PEX5 knockout mouse). Am. J. Pathol. 159: 1477–1494.
   PubMedGoogle Scholar
• Bjorkman, J., S. J. Gould, and D. I. Crane. 2002. Pex13, the mouse ortholog of the human peroxisome biogenesis disorder PEX13 gene: gene structure, tissue expression, and localization of the protein to peroxisomes. Genomics 79: 162–168.
   PubMedGoogle Scholar
• Bjorkman, J., I. Tonks, M. A. Maxwell, C. Paterson, G. F. Kay, and D. I. Crane. 2002. Conditional inactivation of the peroxisome biogenesis Pex13 gene by Cre-loxP excision. Genesis 32: 179–180.
   PubMedGoogle Scholar
• Chen, N., and D. I. Crane. 1992. Induction of the major integral membrane protein of mouse liver peroxisomes by peroxisome proliferators. Biochem. J. 283: 605–610.
   PubMedGoogle Scholar
• Crane, D. I., A. C. Hemsley, and C. J. Masters. 1985. Purification of peroxisomes from livers of normal and clofibrate-treated mice. Anal. Biochem. 148: 436–445.
   PubMedGoogle Scholar
• Dammai, V., and S. Subramani. 2001. The human peroxisomal targeting signal receptor, Pex5p, is translocated into the peroxisomal matrix and recycled to the cytosol. Cell 105: 187–196.
   PubMed Web of Science ®Google Scholar
• Distel, B., R. Erdmann, S. J. Gould, G. Blobel, D. I. Crane, J. M. Cregg, G. Dodt, Y. Fujiki, J. M. Goodman, W. W. Just, J. A. Kiel, W. H. Kunau, P. B. Lazarow, G. P. Mannaerts, H. W. Moser, T. Osumi, R. A. Rachubinski, A. Roscher, S. Subramani, H. F. Tabak, T. Tsukamoto, D. Valle, I. van der Klei, P. P. van Veldhoven, and M. Veenhuis. 1996. A unified nomenclature for peroxisome biogenesis factors. J. Cell Biol. 135: 1–3.
   PubMedGoogle Scholar
• Elgersma, Y., L. Kwast, A. Klein, T. Voorn-Brouwer, M. van den Berg, B. Metzig, T. America, H. F. Tabak, and B. Distel. 1996. The SH3 domain of the Saccharomyces cerevisiae peroxisomal membrane protein Pex13p functions as a docking site for Pex5p, a mobile receptor for the import PTS1-containing proteins. J. Cell Biol. 135: 97–109.
   PubMedGoogle Scholar
• Erdmann, R., and G. Blobel. 1996. Identification of Pex13p, a peroxisomal membrane receptor for the PTS1 recognition factor. J. Cell Biol. 135: 111–121.
   PubMed Web of Science ®Google Scholar
• Fahimi, H. D. 1979. An assessment of the DAB methods for cytochemical detection of catalase and peroxidase. J. Histochem. Cytochem. 27: 1365–1366.
   PubMedGoogle Scholar
• Faust, P. L., and M. E. Hatten. 1997. Targeted deletion of the PEX2 peroxisome assembly gene in mice provides a model for Zellweger syndrome, a human neuronal migration disorder. J. Cell Biol. 139: 1293–1305.
   PubMedGoogle Scholar
• Faust, P. L., H. M. Su, A. Moser, and H. W. Moser. 2001. The peroxisome deficient PEX2 Zellweger mouse: pathologic and biochemical correlates of lipid dysfunction. J. Mol. Neurosci. 16: 289-297.
   PubMed Web of Science ®Google Scholar
• Goldfischer, S., C. L. Moore, A. B. Johnson, A. J. Spiro, M. P. Valsamis, H. K. Wisniewski, R. H. Ritch, W. T. Norton, I. Rapin, and L. M. Gartner. 1973. Peroxisomal and mitochondrial defects in the cerebro-hepato-renal syndrome. Science 182: 62–64.
   PubMed Web of Science ®Google Scholar
• Gould, S. J., J. E. Kalish, J. C. Morrell, J. Bjorkman, A. J. Urquhart, and D. I. Crane. 1996. Pex13p is an SH3 protein of the peroxisome membrane and a docking factor for the predominantly cytoplasmic PTS1 receptor. J. Cell Biol. 135: 85–95.
   PubMed Web of Science ®Google Scholar
• Gould, S. J., and D. Valle. 2000. Peroxisome biogenesis disorders: genetics and cell biology. Trends Genet. 16: 340–345.
   PubMed Web of Science ®Google Scholar
• Gould, S. J., D. Valle, and G. V. Raymond. 2001. The peroxisome biogenesis disorders, p. 3181-3217. In C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle (ed.), The metabolic and molecular bases of inherited disease, 8th ed., vol. 2. McGraw-Hill, New York, N.Y.
   Google Scholar
• Gressens, P., M. Baes, P. Leroux, A. Lombet, P. Van Veldhoven, A. Janssen, J. Vamecq, S. Marret, and P. Evrard. 2000. Neuronal migration disorder in Zellweger mice is secondary to glutamate receptor dysfunction. Ann. Neurol. 48: 336–343.
   PubMedGoogle Scholar
• Hughes, J. L., D. I. Crane, E. Robertson, and A. Poulos. 1993. Morphometry of peroxisomes and immunolocalization of peroxisomal proteins in the liver of patients with generalised peroxisomal disorders. Virchows Arch. A Pathol. Anat. 423: 459–468.
   Google Scholar
• Hughes, J. L., A. Poulos, D. I. Crane, C. W. Chow, L. J. Sheffield, and D. Sillence. 1992. Ultrastructure and immunocytochemistry of hepatic peroxisomes in rhizomelic chondrodysplasia punctata. Eur. J. Pediatr. 151: 829–836.
   PubMed Web of Science ®Google Scholar
• Kwan, K.-M. 2002. Conditional alleles in mice: practical considerations for tissue specific knockouts. Genesis 32: 49–62.
   PubMedGoogle Scholar
• Li, X., E. Baumgart, J. C. Morrell, G. Jimenez-Sanchez, D. Valle, and S. J. Gould. 2002. PEX11β deficiency is lethal and impairs neuronal migration but does not abrogate peroxisome function. Mol. Cell. Biol. 22: 4358–4365.
   PubMed Web of Science ®Google Scholar
• Liu, Y., J. Bjorkman, A. Urquhart, R. J. Wanders, D. I. Crane, and S. J. Gould. 1999. PEX13 is mutated in complementation group 13 of the peroxisome-biogenesis disorders. Am. J. Hum. Genet. 65: 621–634.
   PubMedGoogle Scholar
• Maxwell, M. A., T. Allen, P. Solley, T. Svingen, B. C. Paton, and D. I. Crane. 2002. Novel PEX1 mutations and genotype-phenotype correlations in Australasian peroxisome biogenesis disorder patients. Hum. Mut. 20: 342–351.
   PubMedGoogle Scholar
• Maxwell, M. A., P. V. Nelson, S. J. Chin, B. C. Paton, W. F. Carey, and D. I. Crane. 1999. A common PEX1 frameshift mutation in patients with disorders of peroxisome biogenesis correlates with the severe Zellweger syndrome phenotype. Hum. Genet. 105: 38–44.
   PubMedGoogle Scholar
• Moser, H. W. 1996. Pathogenetic mechanisms in peroxisomal disorders. Curr. Opin. Neurol. 9: 473–476.
   PubMedGoogle Scholar
• Moser, H. W. 1993. Peroxisomal diseases. Adv. Hum. Genet. 21: 1–106.
   PubMedGoogle Scholar
• Moser, H. W. 1999. Peroxisomal disorders: classification and overview of biochemical abnormalities. Rev. Neurol. 28(Suppl. 1): S45-S48.
   PubMedGoogle Scholar
• Nagy, A. 2000. Cre recombinase: the universal reagent for genome tailoring. Genesis 26: 99–109.
   PubMed Web of Science ®Google Scholar
• Otera, H., T. Harano, M. Honsho, K. Ghaedi, S. Mukai, A. Tanaka, A. Kawai, N. Shimizu, and Y. Fujiki. 2000. The mammalian peroxin Pex5pL, the longer isoform of the mobile peroxisome targeting signal (PTS) type 1 transporter, translocates the Pex7p.PTS2 protein complex into peroxisomes via its initial docking site, Pex14p. J. Biol. Chem. 275: 21703–21714.
   PubMedGoogle Scholar
• Otera, H., K. Setoguchi, M. Hamasaki, T. Kumashiro, N. Shimizu, and Y. Fujiki. 2002. Peroxisomal targeting signal receptor Pex5p interacts with cargoes and import machinery components in a spatiotemporally differentiated manner: conserved Pex5p WXXXF/Y motifs are critical for matrix protein import. Mol. Cell. Biol. 22: 1639–1655.
   PubMedGoogle Scholar
• Paton, B. C., P. C. Sharp, D. I. Crane, and A. Poulos. 1996. Oxidation of pristanic acid in fibroblasts and its application to the diagnosis of peroxisomal beta-oxidation defects. J. Clin. Investig. 97: 681–688.
   PubMedGoogle Scholar
• Poulos, A., R. Gibson, P. Sharp, K. Beckman, and P. Grattan-Smith. 1994. Very long chain fatty acids in X-linked adrenoleukodystrophy brain after treatment with Lorenzo's oil. Ann. Neurol. 36: 741–746.
   PubMedGoogle Scholar
• Poulos, A., L. Sheffield, P. Sharp, G. Sherwood, D. Johnson, K. Beckman, A. J. Fellenberg, J. E. Wraith, C. W. Chow, S. Usher, and H. Singh. 1988. Rhizomelic chondrodysplasia punctata: clinical, pathologic and biochemical findings in two patients. J. Pediatr. 113: 685–690.
   PubMed Web of Science ®Google Scholar
• Purdue, P. E., and P. B. Lazarow. 2001. Peroxisome biogenesis. Annu. Rev. Cell Dev. Biol. 17: 701–752.
   PubMed Web of Science ®Google Scholar
• Purdue, P. E., and P. B. Lazarow. 1996. Targeting of human catalase to peroxisomes is dependent upon a novel COOH-terminal peroxisomal targeting sequence. J. Cell Biol. 134: 849–862.
   PubMedGoogle Scholar
• Schwenk, F., U. Baron, and K. Rajewsky. 1995. A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res. 23: 5080–5081.
   PubMed Web of Science ®Google Scholar
• Sheikh, F. G., K. Pahan, M. Khan, E. Barbosa, and I. Singh. 1998. Abnormality in catalase import into peroxisomes leads to severe neurological disorder. Proc. Natl. Acad. Sci. USA 95: 2961–2966.
   PubMedGoogle Scholar
• Shimozawa, N., Y. Suzuki, Z. Zhang, A. Imamura, R. Toyama, S. Mukai, Y. Fujiki, T. Tsukamoto, T. Osumi, T. Orii, R. J. Wanders, and N. Kondo. 1999. Nonsense and temperature-sensitive mutations in PEX13 are the cause of complementation group H of peroxisome biogenesis disorders. Hum. Mol. Genet. 8: 1077–1083.
   PubMed Web of Science ®Google Scholar
• Stein, K., A. Schell-Steven, R. Erdmann, and H. Rottensteiner. 2002. Interactions of Pex7p and Pex18p/Pex21p with the peroxisomal docking machinery: implications for the first steps in PTS2 protein import. Mol. Cell. Biol. 22: 6056–6069.
   PubMedGoogle Scholar
• Toyama, R., S. Mukai, A. Itagaki, S. Tamura, N. Shimozawa, Y. Suzuki, N. Kondo, R. J. Wanders, and Y. Fujiki. 1999. Isolation, characterization and mutation analysis of PEX13-defective Chinese hamster ovary cell mutants. Hum. Mol. Genet. 8: 1673–1681.
   PubMedGoogle Scholar
• Urquhart, A. J., D. Kennedy, S. J. Gould, and D. I. Crane. 2000. Interaction of Pex5p, the type 1 peroxisome targeting signal receptor, with the peroxisomal membrane proteins Pex14p and Pex13p. J. Biol. Chem. 275: 4127–4136.
   PubMed Web of Science ®Google Scholar